Successful Treatment with Selpercatinib after Pralsetinib-Related Pneumonitis and Intracranial Failure in a Patient with RET-rearranged Nonsmall Cell Lung Cancer.
ANTI-CANCER DRUGS（2024）
Key words
intracranial efficacy,nonsmall cell lung cancer,pulmonary toxicity,RET-rearrangement,selpercatinib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined